Afghanistan - Incidence of tuberculosis (per 100,000 people)

Incidence of tuberculosis (per 100,000 people) in Afghanistan was reported at 189 in 2015, according to the World Bank collection of development indicators, compiled from officially recognized sources.



afghanistan incidence of tuberculosis per 100 000 people wb data
width
height
 Preview
Forecast Data Chart
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us



Incidence of tuberculosis is the estimated number of new pulmonary, smear positive, and extra-pulmonary tuberculosis cases.


Afghanistan | Health

Proportion of women subjected to physical and/or sexual violence in the last 12 months ( % of women age 15-49)
46.1 %
Women who believe a husband is justified in beating his wife when she argues with him (%)
59.2 %
Women who believe a husband is justified in beating his wife when she burns the food (%)
18.2 %
Women who believe a husband is justified in beating his wife when she goes out without telling him (%)
66.9 %
Women who believe a husband is justified in beating his wife when she neglects the children (%)
48.4 %
Women who believe a husband is justified in beating his wife (any of five reasons)
80.2 %
Women who believe a husband is justified in beating his wife when she refuses sex with him (%)
33.4 %
Problems in accessing health care (not wanting to go alone) (% of women): Q1 (lowest)
78.7 %
Problems in accessing health care (not wanting to go alone) (% of women): Q2
75.8 %
Problems in accessing health care (not wanting to go alone) (% of women): Q3
72.3 %
Problems in accessing health care (not wanting to go alone) (% of women): Q4
68.1 %
Problems in accessing health care (not wanting to go alone) (% of women): Q5 (highest)
52.3 %
Problems in accessing health care (distance to health facility) (% of women): Q1 (lowest)
80.3 %
Problems in accessing health care (distance to health facility) (% of women): Q2
73.8 %
Problems in accessing health care (distance to health facility) (% of women): Q3
71.6 %
Problems in accessing health care (distance to health facility) (% of women): Q4
64.4 %
Problems in accessing health care (distance to health facility) (% of women): Q5 (highest)
44.6 %
Problems in accessing health care (getting money for treatment) (% of women): Q1 (lowest)
74.1 %
Problems in accessing health care (getting money for treatment) (% of women): Q2
71 %
Problems in accessing health care (getting money for treatment) (% of women): Q3
72.4 %
Problems in accessing health care (getting money for treatment) (% of women): Q4
65.8 %
Problems in accessing health care (getting money for treatment) (% of women): Q5 (highest)
49.6 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q1 (lowest)
56.6 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q2
56.9 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q3
56.6 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q4
49.9 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q5 (highest)
31.9 %
Problems in accessing health care (any of the specified problems) (% of women): Q1 (lowest)
94.2 %
Problems in accessing health care (any of the specified problems) (% of women): Q2
91.8 %
Problems in accessing health care (any of the specified problems) (% of women): Q3
90.7 %
Problems in accessing health care (any of the specified problems) (% of women): Q4
88.9 %
Problems in accessing health care (any of the specified problems) (% of women): Q5 (highest)
76.6 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
1
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
42 %
Prevalence of anemia among children (% of children under 5)
46.4 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
42.4 %
Number of deaths ages 5-14 years
9615
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
39.4 %
Number of infant deaths
60384
Cause of death, by injury (% of total)
18.1 %
Number of under-five deaths
79856
Cause of death, by non-communicable diseases (% of total)
42.3 %
Number of neonatal deaths
45889
Probability of dying at age 5-14 years (per 1,000 children age 5)
9.5
Adults (ages 15+) living with HIV
7200 Persons
AIDS estimated deaths (UNAIDS estimates)
500
Female adults with HIV (% of population ages 15+ with HIV)
28.63 %
Prevalence of HIV, total (% of population ages 15-49)
0.1 %
Mortality rate, under-5 (per 1,000)
70.4
Mortality rate, under-5, female (per 1,000 live births)
66.4
Mortality rate, under-5, male (per 1,000 live births)
74.3
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
81
Under-5 mortality rate (per 1,000 live births): Q2
64
Under-5 mortality rate (per 1,000 live births): Q3
71
Under-5 mortality rate (per 1,000 live births): Q4
51
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
40
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
31 %
Mortality rate; neonatal (per 1;000 live births)
40
Median age at first birth (women ages 25-49): Q1 (lowest)
19.7
Median age at first birth (women ages 25-49): Q2
20.2
Median age at first birth (women ages 25-49): Q3
20.3
Median age at first birth (women ages 25-49): Q4
19.9
Median age at first birth (women ages 25-49): Q5 (highest)
20.3
Median age at first marriage (women ages 25-49): Q1 (lowest)
18.1
Median age at first marriage (women ages 25-49): Q2
18.6
Median age at first marriage (women ages 25-49): Q3
18.8
Median age at first marriage (women ages 25-49): Q4
18.4
Median age at first marriage (women ages 25-49): Q5 (highest)
18.6
Median age at first sexual intercourse (women ages 25-49): Q1 (lowest)
18.3
Median age at first sexual intercourse (women ages 25-49): Q2
18.9
Median age at first sexual intercourse (women ages 25-49): Q3
18.9
Median age at first sexual intercourse (women ages 25-49): Q4
18.7
Median age at first sexual intercourse (women ages 25-49): Q5 (highest)
18.8
Heard family planning on radio and television (% of women): Q1 (lowest)
10 %
Heard family planning on radio and television (% of women): Q2
20.9 %
Heard family planning on radio and television (% of women): Q3
23.8 %
Heard family planning on radio and television (% of women): Q4
27.3 %
Heard family planning on radio and television (% of women): Q5 (highest)
26.3 %
Desire to stop (limit) childbearing (% of married women): Q1 (lowest)
20.7 %
Desire to stop (limit) childbearing (% of married women): Q2
20.1 %
Desire to stop (limit) childbearing (% of married women): Q3
22.1 %
Desire to stop (limit) childbearing (% of married women): Q4
26.9 %
Desire to stop (limit) childbearing (% of married women): Q5 (highest)
38.1 %
Median birth interval (months): Q1 (lowest)
29.5
Median birth interval (months): Q2
27.5
Median birth interval (months): Q3
26.9
Median birth interval (months): Q4
28.2
Median birth interval (months): Q5 (highest)
31.7
Family planning messages in print (% of women): Q1 (lowest)
0.3 %
Family planning messages in print (% of women): Q2
0.2 %
Family planning messages in print (% of women): Q3
0.6 %
Family planning messages in print (% of women): Q4
1.5 %
Family planning messages in print (% of women): Q5 (highest)
6.7 %
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
42.1 %
People using basic drinking water services (% of population): Q1 (lowest)
39.17 %
People using basic drinking water services, rural (% of rural population): Q2
39.84 %
Children (0-14) living with HIV
500 Persons
Prevalence of HIV, female (% ages 15-24)
0.1 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
1
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)
6.3
Prevalence of HIV, male (% ages 15-24)
0.1 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
7 %
Adults (ages 15+) newly infected with HIV
1000
Children (ages 0-14) newly infected with HIV
100
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
1000
Incidence of HIV (% of uninfected population ages 15-49)
0.01 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
1.2 %
% of males ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
4.9 %
Children orphaned by HIV/AIDS
4500
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
5 %
Adults (ages 15+) and children (0-14 years) living with HIV
7500 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
23.1 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
30 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
28.2 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
32.7 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
37.3 %
Immunization, Hib3 (% of children ages 12-23 months)
65 %
Immunization, BCG (% of one-year-old children)
74 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
54.4 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
63 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
59.8 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
66.8 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
79.3 %
Immunization, DPT (% of children ages 12-23 months)
65 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
28.9 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
40.1 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
36.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
43.5 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
54.4 %
Immunization, measles (% of children ages 12-23 months)
62 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
43.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
55.6 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
52.2 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
59.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
68.1 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
27.6 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
24.3 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
28.1 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
25.8 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
13 %
Immunization, Pol3 (% of one-year-old children)
60 %
Hospital beds
0.5
Nurses and midwives
0.36
Physicians
0.295
Notified cases of malaria (per 100;000 people)
21852
Mosquito net use by children (any mosquito net) (% of children under 5): Q1 (lowest)
1.6 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q2
4.4 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q3
6.9 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q4
9.5 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q5 (highest)
10.8 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q1 (lowest)
28.3 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q2
37.5 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q3
42.4 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q4
43.1 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q5 (highest)
31.4 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q1 (lowest)
1.1 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q2
4.2 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q3
5.8 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q4
8.7 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q5 (highest)
15.4 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q2
3.3 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q3
5.5 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q4
6.8 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q1 (lowest)
21.2 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q2
28.2 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q3
29.5 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q4
31.5 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q5 (highest)
19.6 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q1 (lowest)
0.8 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q2
3 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q3
4.6 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q4
5.2 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q5 (highest)
9.3 %
Treatment of fever (% of children under 5 with fever): Q1 (lowest)
11.2 %
Treatment of fever (% of children under 5 with fever): Q2
13 %
Treatment of fever (% of children under 5 with fever): Q3
8.4 %
Treatment of fever (% of children under 5 with fever): Q4
9 %
Treatment of fever (% of children under 5 with fever): Q5 (highest)
18 %
Children with fever receiving antimalarial drugs (% of children under age 5 with fever)
11.8 %
Number of maternal mortality deaths
4300
Lifetime risk of maternal death (1 in: rate varies by country)
52
Lifetime risk of maternal death
1.93 %
Prevalence of anemia among pregnant women
38.2 %
Prevalence of syphilis (% of women attending antenatal care)
0.6 %
Smoking prevalence, females (% of adults)
17 %
Smoking (% of women): Q1 (lowest)
10.3 %
Smoking (% of women): Q2
7.1 %
Smoking (% of women): Q3
6.1 %
Smoking (% of women): Q4
3.2 %
Smoking (% of women): Q5 (highest)
3.4 %
Smoking prevalence, males (% of adults)
82 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
92.8 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
83.1 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q1 (lowest)
36.9 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q2
35.6 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q3
39.7 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q4
44.9 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q5 (highest)
55 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
17.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
50.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
51 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
54.3 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
64.1 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
76.3 %
Pregnant women receiving prenatal care
58.6 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
19.6 %
Antenatal care (doctor) (% of women with a birth): Q2
23.1 %
Antenatal care (doctor) (% of women with a birth): Q3
26.6 %
Antenatal care (doctor) (% of women with a birth): Q4
35.6 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
50.3 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
52.9 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
65.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
56.3 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
67.1 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
70 %
ARI treatment (% of children under 5 taken to a health provider)
61.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
16.2 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
11.9 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
12.8 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
11.3 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
10.8 %
Exclusive breastfeeding (% of children under 6 months)
43.13 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
26.9 %
Assistance during delivery (any skilled personnel) (% of births): Q2
39.7 %
Assistance during delivery (any skilled personnel) (% of births): Q3
47.1 %
Assistance during delivery (any skilled personnel) (% of births): Q4
68.6 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
88 %
Births attended by skilled health staff (% of total)
50.5 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
25 %
Place of delivery (births at health facility) (% of births): Q2
37 %
Place of delivery (births at health facility) (% of births): Q3
44.5 %
Place of delivery (births at health facility) (% of births): Q4
66.1 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
85.7 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
4.9 %
Assistance during delivery (doctor) (% of births): Q2
8.9 %
Assistance during delivery (doctor) (% of births): Q3
13.4 %
Assistance during delivery (doctor) (% of births): Q4
22.5 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
43 %
Low-birthweight babies (% of births)
20 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
30.1 %
Prevalence of diarrhea (% of children under 5): Q2
29.6 %
Prevalence of diarrhea (% of children under 5): Q3
31.7 %
Prevalence of diarrhea (% of children under 5): Q4
34.7 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
35.7 %
Prevalence of children with fever (% of children under 5): Q1 (lowest)
28.8 %
Prevalence of children with fever (% of children under 5): Q2
27.4 %
Prevalence of children with fever (% of children under 5): Q3
29.9 %
Prevalence of children with fever (% of children under 5): Q4
27.8 %
Prevalence of children with fever (% of children under 5): Q5 (highest)
29.9 %
Infant and young child feeding practices, all 3 IYCF (% children ages 6-23 months)
15.5 %
Prevalence of underweight, weight for age, female (% of children under 5)
33 %
Prevalence of underweight, weight for age, male (% of children under 5)
32.7 %
Malnutrition prevalence, weight for age (% of children under 5)
32.9 %
Malaria cases reported
86895
Maternal mortality ratio (modeled estimate, per 100,000 live births)
396
Maternal mortality ratio (national estimate; per 100;000 live births)
1291
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
40.7 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q1 (lowest)
43.3 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q2
38.1 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q3
45.8 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q4
38.8 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q5 (highest)
41.3 %
Knowledge of diarrhea care (% of mothers): Q1 (lowest)
65.4 %
Knowledge of diarrhea care (% of mothers): Q2
65.2 %
Knowledge of diarrhea care (% of mothers): Q3
59.7 %
Knowledge of diarrhea care (% of mothers): Q4
67.5 %
Knowledge of diarrhea care (% of mothers): Q5 (highest)
66 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q1 (lowest)
49.5 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q2
53.4 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q3
47.8 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q4
54.2 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q5 (highest)
46.9 %
Diarrhea treatment (% of children under 5 who received ORS packet)
46.2 %
Prevalence of overweight, female (% of female adults)
26.1 %
Prevalence of overweight, male (% of male adults)
19.7 %
Prevalence of overweight (% of adults)
23 %
Prevalence of overweight, weight for height, female (% of children under 5)
2.6 %
Prevalence of overweight, weight for height, male (% of children under 5)
6.3 %
Prevalence of overweight (% of children under 5)
4.6 %
Postnatal care coverage (% mothers)
39.9 %
Prevalence of stunting, height for age, female (% of children under 5)
58.5 %
Prevalence of stunting, height for age, male (% of children under 5)
60 %
Malnutrition prevalence, height for age (% of children under 5)
59.3 %
Mortality caused by road traffic injury (per 100,000 people)
15.2
Prevalence of wasting, weight for height, female (% of children under 5)
9.3 %
Prevalence of wasting, weight for height, male (% of children under 5)
7.9 %
Prevalence of wasting (% of children under 5)
8.6 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
4.3 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
2.9 %
Prevalence of severe wasting, weight for height (% of children under 5)
3.5 %
Tuberculosis treatment success rate (% of registered cases)
88 %
Tuberculosis case detection rate (all forms)
64 %
Incidence of tuberculosis (per 100,000 people)
189
Tuberculosis death rate (per 100,000 people)
33
Number of people pushed below the 50% median consumption poverty line by out-of-pocket health care expenditure
277000 %
Proportion of population pushed below the 50% median consumption poverty line by out-of-pocket health care expenditure (%)
1.04 %
Increase in poverty gap at $1.90 ($ 2011 PPP) poverty line due to out-of-pocket health care expenditure (USD)
0.0216
Number of people pushed below the $1.90 ($ 2011 PPP) poverty line by out-of-pocket health care expenditure
154000
Increase in poverty gap at $1.90 ($ 2011 PPP) poverty line due to out-of-pocket health care expenditure (% of poverty line)
0.00248 %
Proportion of population pushed below the $1.90 ($ 2011 PPP) poverty line by out-of-pocket health care expenditure (%)
0.5796 %
Increase in poverty gap at $3.10 ($ 2011 PPP) poverty line due to out-of-pocket health care expenditure (USD)
0.00697
Number of people pushed below the $3.10 ($ 2011 PPP) poverty line by out-of-pocket health care expenditure
678000
Increase in poverty gap at $3.10 ($ 2011 PPP) poverty line due to out-of-pocket health care expenditure (% of poverty line)
0.00131 %
Proportion of population pushed below the $3.10 ($ 2011 PPP) poverty line by out-of-pocket health care expenditure (%)
2.55 %
Number of people spending more than 10% of household consumption or income on out-of-pocket health care expenditure
1288000 %
Proportion of population spending more than 10% of household consumption or income on out-of-pocket health care expenditure (%)
4.84 %
Number of people spending more than 25% of household consumption or income on out-of-pocket health care expenditure
17000 %
Proportion of population spending more than 25% of household consumption or income on out-of-pocket health care expenditure (%)
0.0656 %
Number of people spending more than 40% of non-food consumption or income on out-of-pocket health care expenditure
25000 %
Proportion of population spending more than 40% of non-food consumption or income on out-of-pocket health care expenditure (%)
0.0936 %
UHC service coverage index
34
Tetanus toxoid vaccination (% of live births): Q1 (lowest)
33.4 %
Tetanus toxoid vaccination (% of live births): Q2
32.7 %
Tetanus toxoid vaccination (% of live births): Q3
32.8 %
Tetanus toxoid vaccination (% of live births): Q4
34.2 %
Tetanus toxoid vaccination (% of live births): Q5 (highest)
33.2 %
Newborns protected against tetanus
65 %
External resources for health (% of total expenditure on health)
368 %
Out-of-pocket health expenditure (% of total expenditure on health)
1022 %
Out-of-pocket health expenditure (% of private expenditure on health)
1593 %
Health expenditure per capita
905 USD
Health expenditure per capita, PPP (constant 2005 international $)
2664
Health expenditure, private (% of GDP)
83.99 %
Health expenditure, public (% of total health expenditure)
573 %
Health expenditure, public (% of government expenditure)
192 %
Health expenditure, public (% of GDP)
46.93 %
Health expenditure, total (% of GDP)
131 %
Number of people who are undernourished
7500000
Depth of the food deficit (kilocalories per person per day)
173
Consumption of iodized salt (% of households)
20.45 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
18.3 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
18.5 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
20.9 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
27 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
31.9 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
49.4 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
44.1 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
41.7 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
51.6 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
51 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
98 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
68.79
Mortality rate, adult, female (per 1,000 female adults)
202
Mortality rate, adult, male (per 1,000 male adults)
245
Birth rate, crude
33.21
Death rate, crude
6.75
Current use of contraception (modern method) (% of married women): Q1 (lowest)
15 %
Current use of contraception (modern method) (% of married women): Q2
16.1 %
Current use of contraception (modern method) (% of married women): Q3
15.7 %
Current use of contraception (modern method) (% of married women): Q4
22 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
30.5 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
19.8 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
15.8 %
Current use of contraception (any method) (% of married women): Q2
17.4 %
Current use of contraception (any method) (% of married women): Q3
17.5 %
Current use of contraception (any method) (% of married women): Q4
25.6 %
Current use of contraception (any method) (% of married women): Q5 (highest)
36.6 %
Contraceptive prevalence (% of women ages 15-49)
22.5 %
Mortality rate, infant, female (per 1,000 live births)
49.2
Mortality rate, infant (per 1,000 live births)
53.2
Mortality rate, infant, male (per 1,000 live births)
56.9
Infant mortality rate (per 1,000 live births): Q1 (lowest)
62
Infant mortality rate (per 1,000 live births): Q2
51
Infant mortality rate (per 1,000 live births): Q3
57
Infant mortality rate (per 1,000 live births): Q4
41
Infant mortality rate (per 1,000 live births): Q5 (highest)
35
Life expectancy at birth, female (years)
65.02 years
Life expectancy at birth, total (years)
63.67 years
Life expectancy at birth, male (years)
62.41 years
Fertility rate, total (births per woman)
4.64
Total fertility rate (TFR) (births per woman): Q1 (lowest)
5.3
Total fertility rate (TFR) (births per woman): Q2
5.4
Total fertility rate (TFR) (births per woman): Q3
5.8
Total fertility rate (TFR) (births per woman): Q4
5.3
Total fertility rate (TFR) (births per woman): Q5 (highest)
4.6
Survival to age 65, female (% of cohort)
66.59 %
Survival to age 65, male (% of cohort)
60.47 %
Wanted fertility rate (births per woman)
4.4
Total wanted fertility rate (births per woman): Q1 (lowest)
4.5
Total wanted fertility rate (births per woman): Q2
4.6
Total wanted fertility rate (births per woman): Q3
4.9
Total wanted fertility rate (births per woman): Q4
4.4
Total wanted fertility rate (births per woman): Q5 (highest)
3.4
Female headed households (% of households with a female head)
1.7 %
Women who were first married by age 18 (% of women ages 20-24)
34.8 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q1 (lowest)
14.6 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q2
12.9 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q3
13.4 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q4
11.1 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q5 (highest)
9.1 %
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
12.1 %
Completeness of birth registration, rural
36 %
Completeness of birth registration, urban
63.5 %
Completeness of birth registration
42.3 %
Unmet need for family planning (for limiting) (% of married women): Q1 (lowest)
6.9 %
Unmet need for family planning (for limiting) (% of married women): Q2
6.6 %
Unmet need for family planning (for limiting) (% of married women): Q3
6 %
Unmet need for family planning (for limiting) (% of married women): Q4
6.7 %
Unmet need for family planning (for limiting) (% of married women): Q5 (highest)
9 %
Unmet need for family planning (for spacing) (% of married women): Q1 (lowest)
20 %
Unmet need for family planning (for spacing) (% of married women): Q2
18.2 %
Unmet need for family planning (for spacing) (% of married women): Q3
18.5 %
Unmet need for family planning (for spacing) (% of married women): Q4
18.1 %
Unmet need for family planning (for spacing) (% of married women): Q5 (highest)
12.3 %
Unmet need for contraception (% of married women ages 15-49)
24.5 %
Unmet need for family planning (total) (% of married women): Q1 (lowest)
26.8 %
Unmet need for family planning (total) (% of married women): Q2
24.8 %
Unmet need for family planning (total) (% of married women): Q3
24.5 %
Unmet need for family planning (total) (% of married women): Q4
24.8 %
Unmet need for family planning (total) (% of married women): Q5 (highest)
21.3 %






Related
Latest